Medicare Enrolled
Dr. Deborah Glick, M.D.
Hematology · Naples, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Glick from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Glick? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Glick
Dr. Deborah Glick is a hematology in Naples, FL, with 19 years in practice. Based on federal Medicare data, Dr. Glick performed 184,407 Medicare services across 5,426 unique beneficiaries.
Between the years covered by Open Payments, Dr. Glick received a total of $7,578 from 61 pharmaceutical and/or device companies across 210 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Glick is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 25% volume in FL$ $7,578 industry payments
Medicare Practice Summary
Medicare Utilization ↗184,407
Medicare services
Top 25% in FL for hematology
5,426
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~9,706 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 95,880 | $0 | $4 |
| Epoetin alfa injection (Procrit) for anemia | 17,150 | $6 | $23 |
| Filgrastim injection (Zarxio) for white blood cells | 12,360 | $0 | $2 |
| Iron sucrose injection (Venofer) | 11,200 | $0 | $5 |
| Azacitidine chemotherapy injection | 10,136 | $0 | $4 |
| Pembrolizumab injection (Keytruda) | 5,400 | $42 | $137 |
| Denosumab injection (Prolia/Xgeva) | 5,040 | $19 | $51 |
| Immune globulin infusion (Gammagard) | 4,478 | $36 | $108 |
| Daratumumab injection (Darzalex) | 3,600 | $36 | $110 |
| Complete blood count (CBC) with differential | 3,048 | $8 | $29 |
| Blood draw (venipuncture) | 2,987 | $8 | $9 |
| Anti-nausea injection (aprepitant) | 2,600 | $1 | $5 |
| Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 1,850 | $24 | $185 |
| Office visit, established patient (30-39 min) | 1,155 | $94 | $339 |
| Iron infusion (Monoferric) | 1,100 | $17 | $57 |
| Drug injection, under skin or into muscle | 1,077 | $11 | $69 |
| Dexamethasone injection (steroid) | 1,009 | $0 | $3 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 446 | $1 | $6 |
| Anti-nausea injection (ondansetron/Zofran) | 420 | $0 | $9 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 347 | $50 | $189 |
| Anti-nausea injection (Aloxi/palonosetron) | 290 | $1 | $28 |
| Injection of additional new drug or substance into vein | 234 | $12 | $61 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 224 | $18 | $59 |
| Administration of chemotherapy into vein, 1 hour or less | 205 | $104 | $378 |
| New patient office visit (45-59 min) | 180 | $125 | $453 |
| Red blood count, automated test | 160 | $4 | $10 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 159 | $16 | $56 |
| Administration of chemotherapy into vein, each additional hour | 152 | $22 | $79 |
| Injection, diphenhydramine hcl, up to 50 mg | 145 | $1 | $3 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 138 | $23 | $84 |
| Infusion into a vein for hydration, each additional hour | 129 | $10 | $42 |
| Office visit, established patient, complex (40-54 min) | 116 | $143 | $474 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 112 | $3 | $11 |
| Injection, fluorouracil, 500 mg | 111 | $2 | $7 |
| Infusion, normal saline solution , 1000 cc | 105 | $2 | $7 |
| Infusion into a vein for hydration, 31-60 minutes | 94 | $26 | $156 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 91 | $54 | $206 |
| Injection of drug or substance into vein | 84 | $29 | $156 |
| Drawing of blood for a medical problem | 55 | $72 | $277 |
| Injection, zoledronic acid, 1 mg | 54 | $6 | $69 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 48 | $1 | $7 |
| Initial hospital admission, high complexity | 47 | $138 | $556 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 37 | $27 | $89 |
| Office visit, established patient (20-29 min) | 33 | $71 | $239 |
| Red blood count automated, with additional calculations | 30 | $5 | $20 |
| Administration of additional new drug or substance into vein, 1 hour or less | 26 | $52 | $178 |
| Automated urinalysis | 19 | $2 | $8 |
| Prothrombin time test (blood clotting) | 19 | $4 | $15 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 15 | $140 | $637 |
| Initial hospital admission, moderate complexity | 12 | $89 | $377 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
55.6% high complexity
40.0% medium
4.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,578
Total received (2018-2024)
Avg $1,083/year across 7 years
Top 49% in FL for hematology
61
Companies
210
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,032 (53.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,546 (46.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,141
2023$2,605
2022$1,753
2021$503
2020$322
2019$171
2018$84
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$2,284
BeiGene USA, Inc.
$1,255
AstraZeneca Pharmaceuticals LP
$756
Merck Sharp & Dohme LLC
$372
SOBI, INC
$258
Astellas Pharma US Inc
$241
Celgene Corporation
$206
PFIZER INC.
$133
Daiichi Sankyo Inc.
$132
GENZYME CORPORATION
$113
Incyte Corporation
$95
Octapharma USA, Inc.
$83
Takeda Pharmaceuticals U.S.A., Inc.
$82
Kite Pharma, Inc.
$72
E.R. Squibb & Sons, L.L.C.
$64
ABBVIE INC.
$64
Myriad Genetic Laboratories, Inc.
$63
Jazz Pharmaceuticals Inc.
$61
TAIHO ONCOLOGY, INC.
$60
Kyowa Kirin, Inc.
$58
Novartis Pharmaceuticals Corporation
$56
Merck Sharp & Dohme Corporation
$54
Seagen Inc.
$49
ADC Therapeutics America, Inc.
$47
Pharmacyclics LLC, An AbbVie Company
$42
Genentech USA, Inc.
$41
Amgen Inc.
$40
JAZZ PHARMACEUTICALS INC.
$39
AbbVie Inc.
$36
GlaxoSmithKline, LLC.
$34
Karyopharm Therapeutics Inc.
$33
GE HEALTHCARE
$32
Stemline Therapeutics Inc.
$31
Clovis Oncology, Inc.
$27
Legend Biotech USA Inc.
$27
Heron Therapeutics, Inc.
$27
TerSera Therapeutics LLC
$27
PUMA BIOTECHNOLOGY, INC.
$26
Genmab U.S., Inc.
$25
Biocon Biologics Inc
$25
PharmaEssentia USA Corporation
$24
Agios Pharmaceuticals, Inc.
$24
NanoString Technologies, Inc.
$24
Mirati Therapeutics, Inc.
$23
Exelixis Inc.
$23
Gilead Sciences, Inc.
$23
Sysmex Inostics Inc
$22
Fennec Pharmaceuticals, Inc.
$22
Tempus AI, Inc
$22
Sun Pharmaceutical Industries Inc.
$21
SERVIER PHARMACEUTICALS LLC
$19
Acceleron Pharma, Inc.
$18
AMAG Pharmaceuticals, Inc.
$18
Immunomedics, Inc.
$18
Eisai Inc.
$17
Ipsen Biopharmaceuticals, Inc
$16
Bayer HealthCare Pharmaceuticals Inc.
$15
Aurobindo Pharma USA, Inc.
$15
Horizon Pharma plc
$15
Dendreon Pharmaceuticals LLC
$14
Acrotech Biopharma LLC
$13
Top 3 companies account for 56.7% of total payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · Abraxane · BELEODAQ · BESREMI · BOSULIF · BRUKINSA · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · CERDELGA · CINVANTI · Cinvanti · DARZALEX · DOPTELET · ENHERTU · ENJAYMO · ERLEADA · Enhertu · Epkinly · Erleada · FARESTON · FERAHEME · IBRANCE · IMBRUVICA · INJECTAFER · JAKAFI · KEYTRUDA · KISQALI · KRAZATI · KRYSTEXXA · Kyprolis · LENVIMA · LIBTAYO · LONSURF · LYNPARZA · Lenvima · MONJUVI · NERLYNX · NINLARO · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · OPDIVO · OPDUALAG · Ogivri · Orserdu · PADCEV · PEMAZYRE · PLUVICTO · POTELIGEO · PROSIGNA ASSAY · PROVENGE · PYRUKYND · Pedmark · Perjeta · Phesgo · Pomalyst · Poteligeo · Quzyttir · REBLOZYL · Reblozyl · Rubraca · SOMATULINE DEPOT · TECVAYLI · TIBSOVO · Trodelvy · VENCLEXTA · VONJO · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XPOVIO · XTANDI · Xospata · Xtandi · YONSA · Yescarta · ZEPZELCA · Zevalin · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (53%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Equivalent to $4 per 100 Medicare services performed
Geographic Context
Hematologys within 10 mi
11
Per 100K population
2.8
County median income
$86,173
Nearest hospital
NAPLES COMMUNITY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Glick is a mixed practice specialist, with above-average Medicare volume (top 25% in FL), and consulting-driven industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Glick experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Glick performed 95,880 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Glick receive payments from pharmaceutical companies?
Yes. Dr. Glick received a total of $7,578 from 61 companies across 210 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Glick's costs compare to other hematologys in Naples?
Dr. Glick's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Glick) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologys in Naples
Browse hematologys in Naples ranked by procedure volume and transparency data.
Highest volume
Top Hematologys in FL
Hematologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologys in FL
Which FL hematologys receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
By company
BeiGene USA, Inc. Payments to Doctors
See all physicians who received payments from BeiGene USA, Inc..
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology